Lack of effects of postnatal exposure to a mixture of aryl hydrocarbon-receptor agonists on the development of methylnitrosourea-induced mammary tumors in sprague-dawley rats

Journal of Toxicology and Environmental Health. Part a
D DesaulniersBenjamin K Tsang

Abstract

There are concerns that early life exposure to organochlorines, including aryl hydrocarbon receptor (AhR) agonists, may lead to long-term effects and increase the risk of developing breast cancer. Our objective was to test if postnatal exposure to a mixture of 2,3,7,8-tetrachlorodibenzodioxin (TCDD)-like chemicals would modulate the development of methylnitrosourea (MNU)-induced mammary tumors. Females received by gavage a mixture containing 3 non-ortho-polychlorinated biphenyls (PCBs), 6 polychlorinated dibenzodioxins (PCDDs), and 7 polychlorinated dibenzofurans (PCDFs), at 1, 5, 10, 15, and 20d of age. The doses were equivalent to 0, 1, 10, 100, or 1000 times the amount ingested through breast milk by a human infant during its first 24 d of life. Subgroups of 1000 x reated rats and controls were sacrificed at 21 d of age for assessment of mammary-gland development, cell death, and proliferation. Mammary-tumor development was assessed in MNU (30 mg/kg body weight ip at 50 days of age)-induced rats pre-exposed to the mixture (MNU-0, MNU-1, MNU-10, MNU-100, MNU-1000). Rats were sacrificed when their mammary tumors reached 1 cm in diameter, or when the rats reached > or = 32 wk of age. Mammary-gland whole mounts were analyzed wit...Continue Reading

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Jul 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·S Z Haslam, K A Nummy
Mar 1, 1991·Cancer Causes & Control : CCC·B A MillerB F Hankey
Apr 21, 1990·Lancet·D Trichopoulos
Oct 15, 1987·Cancer·B J KennedyC Mettlin
Sep 1, 1985·Toxicology Letters·A K RobisonG M Stancel
Dec 20, 1995·Journal of the National Cancer Institute·W J Blot, J K McLaughlin
Dec 20, 1995·Journal of the National Cancer Institute·S R SturgeonR N Hoover
Feb 2, 1994·Journal of the National Cancer Institute·E DewaillyJ Brisson
Jan 1, 1996·Epidemiology·M SandersonJ R Daling
Jan 1, 1996·Breast Cancer Research and Treatment·J Russo, I H Russo
Sep 1, 1996·Environmental Health Perspectives·I H Russo, J Russo
Jan 17, 1997·The Journal of Biological Chemistry·R MossiU Hübscher
Jan 15, 1998·Journal of the National Cancer Institute·H L BradlowA Soto
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K NesaretnamP Darbre
Oct 15, 1998·Carcinogenesis·N M BrownC A Lamartiniere
Nov 30, 1998·Environmental Health Perspectives·M Van den BergT Zacharewski
Mar 30, 2000·Chemosphere·F X van LeeuwenM Younes
Apr 4, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·R M BlairD M Sheehan
Jan 4, 2001·Epidemiology·J Wohlfahrt, M Melbye
Jun 16, 2001·British Journal of Pharmacology·U K MessmerJ Pfeilschifter
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·L SivaramanB W O'Malley
Jan 25, 2002·Annals of the New York Academy of Sciences·D MedinaB W Omalle
Jan 25, 2002·Biotechnology and Bioengineering·Tina M SauerwaldGeorge A Oyler
Jan 29, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nichole R Vansell, Curtis D Klaassen
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Nichole R Vansell, Curtis D Klaassen
Apr 10, 2002·Environmental Health Perspectives·Steve WingLawrence Band
Apr 12, 2002·Oncogene·Simone FuldaKlaus-Michael Debatin
Apr 19, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Suzanne E FentonGeri L Youngblood
May 16, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael G WadeClaude Hughes
Jul 16, 2002·Environmental Health Perspectives·Marcella WarnerPaolo Brambilla
Aug 2, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael E WydeNigel J Walker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.